{
    "nctId": "NCT04929808",
    "briefTitle": "Novel Skin Care Product for the Management of Acute Radiodermatitis",
    "officialTitle": "Evaluation of a Novel Skin Care Product for the Management of Acute Radiodermatitis in Breast Cancer Patients",
    "overallStatus": "COMPLETED",
    "conditions": "Radiodermatitis; Acute, Radiation Dermatitis",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 100,
    "primaryOutcomeMeasure": "Skin reaction evaluation",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Diagnosis of breast cancer and underwent lumpectomy or mastectomy\n* Scheduled for radiotherapy: hypofractionation regimen (16 or 16+5 boost fractions) at the Jessa Hospital (Hasselt, BE)\n* Age \u2265 18 years\n* Able to comply to the study protocol\n* Able to sign written informed consent\n* Signed written informed consent\n\nExclusion Criteria:\n\n* Previous irradiation to the breast region\n* Metastatic disease\n* Patients with pre-existing skin rash, ulceration or open wound in the treatment area\n* Substance abuse patients or patients with medical, psychological or social conditions that may interfere with the patient's participation in the study or evaluation of the study results as judged by the investigator \u2022- Any condition that is unstable or could affect the safety of the patient and their compliance in the study as judged by the investigator",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}